文献速递自身免疫性与大疱性皮肤病

自身免疫性大疱病患者胃肠道症状、出血与饮食调查

Gastrointestinal symptoms, gastrointestinal bleeding and the role of diet in patients with autoimmune blistering disease: a survey of the International Pemphigus and Pemphigoid Foundation.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-07-02

基于国际天疱疮与类天疱疮基金会邮件列表的电子调查,收集200例自身免疫性大疱病患者数据。结果显示30.3%患者治疗后出现胃食管反流,诊断后胃肠道出血发生率为2.1%,65.2%患者因疾病限制饮食,酒精、柑橘和辛辣食物不耐受显著。

要点

  • 自身免疫性大疱病患者胃肠道共病常见,诊断后胃肠道出血发生率为2.1%。
  • 使用糖皮质激素尤其联用NSAID者应考虑胃肠道出血预防。
  • 患者常需饮食限制,应警惕酒精、柑橘和辛辣食物。

核心结论

  • 自身免疫性大疱病患者胃肠道共病常见,诊断后胃肠道出血发生率为2.1%。

研究设计与样本

  • 通过国际天疱疮与类天疱疮基金会邮件列表发放电子调查,收集200例自身免疫性大疱病患者数据,以一般人群历史发病率作为对照。

主要发现

  • 30.3%的患者在自身免疫性大疱病治疗后出现胃食管反流,51.7%使用某种胃肠道对症治疗。
  • 自身免疫性大疱病诊断后胃肠道出血发生率为2.1%,校正NSAID使用后仍显著,但校正糖皮质激素使用后不显著。
  • 65.2%的患者报告因自身免疫性大疱病而限制饮食,多重比较校正后酒精、柑橘和辛辣食物不耐受显著。
  • 超过10%的患者报告蔬菜和乳制品可改善疾病。

关键数值与推荐

  • 胃肠道出血发生率为2.1%(自身免疫性大疱病诊断后)。
  • 胃食管反流发生率为30.3%(自身免疫性大疱病治疗后)。
  • 饮食限制报告率为65.2%(因自身免疫性大疱病)。

临床怎么用

  • 接受糖皮质激素尤其联用NSAID的自身免疫性大疱病患者应考虑胃肠道出血预防。
  • 建议患者警惕酒精、柑橘和辛辣食物可能加重疾病。

局限性

  • 研究为基于邮件列表的电子调查,可能存在选择偏倚和回忆偏倚。
  • 以一般人群历史发病率作为对照,非同期对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autoimmune blistering diseases are a group of severe mucocutaneous conditions that typically require the use of prolonged corticosteroids and immunosuppression. Properly managing associated comorbidities is an integral part of these patients' care. The frequency of gastrointestinal symptoms, particularly gastrointestinal bleeding in these patients, is not known. Likewise, the effect of diet on disease is unknown. OBJECTIVE: To determine the incidence of gastrointestinal comorbidities and the role of diet in patients with autoimmune blistering disease. METHODS: We distributed an e-survey to patients with autoimmune blistering disease utilizing the International Pemphigus and Pemphigoid Foundation's listserv. The incidence of gastrointestinal symptoms and gastrointestinal bleeding were recorded, as were foods avoided and those noted to be beneficial in patients' disease. Historical incidences in the general population were used as controls. RESULTS: A total of 200 responses were collected. 30.3% of patients experienced gastroesophageal reflux following treatment of their autoimmune blistering disease, with 51.7% utilizing some form of gastrointestinal symptomatic treatment. The incidence of gastrointestinal bleeding following an autoimmune blistering diagnosis was 2.1%, which remained significant despite correction for non-steroidal anti-inflammatory use (NSAID), but not corticosteroid use. 65.2% of patients reported dietary limitations because of their autoimmune blistering disease. Significant intolerances after correction for multiple comparisons included alcohol, citrus and spicy foods. Greater than 10% of patients reported improvements in their disease with vegetables and dairy. CONCLUSIONS: Gastrointestinal comorbidities are common in patients with autoimmune blistering diseases, with gastrointestinal bleeding occurring in 2.1% of patients following a diagnosis of autoimmune blistering disease. While further work is needed to determine the relative risk of routine gastrointestinal prophylaxis in this population, gastrointestinal bleeding prophylaxis should be considered in patients receiving corticosteroids, particularly those taking NSAIDs. Dietary limitations are additionally frequent in this population. Patients should be cautious of alcohol, citrus and spicy foods.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Kneiber D, Kowalski EH, Kridin K, et al. Gastrointestinal symptoms, gastrointestinal bleeding and the role of diet in patients with autoimmune blistering disease: a survey of the International Pemphigus and Pemphigoid Foundation. J Eur Acad Dermatol Venereol. 2019. PMID: 31169928. doi:10.1111/jdv.15731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。